Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DICLOFENAC Cause Inflammatory bowel disease? 66 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 66 reports of Inflammatory bowel disease have been filed in association with DICLOFENAC (Diclofenac Sodium Delayed Release). This represents 0.1% of all adverse event reports for DICLOFENAC.

66
Reports of Inflammatory bowel disease with DICLOFENAC
0.1%
of all DICLOFENAC reports
2
Deaths
10
Hospitalizations

How Dangerous Is Inflammatory bowel disease From DICLOFENAC?

Of the 66 reports, 2 (3.0%) resulted in death, 10 (15.2%) required hospitalization, and 3 (4.5%) were considered life-threatening.

Is Inflammatory bowel disease Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DICLOFENAC. However, 66 reports have been filed with the FAERS database.

What Other Side Effects Does DICLOFENAC Cause?

Drug ineffective (24,885) Product use in unapproved indication (12,197) Off label use (10,370) Pain (9,276) Product use issue (8,009) Fatigue (7,908) Rash (7,852) Rheumatoid arthritis (7,366) Abdominal discomfort (7,257) Product administered at inappropriate site (6,919)

What Other Drugs Cause Inflammatory bowel disease?

ISOTRETINOIN (692) ADALIMUMAB (517) INFLIXIMAB (444) SECUKINUMAB (440) VEDOLIZUMAB (271) ACCUTANE (223) METHOTREXATE (199) USTEKINUMAB (166) TACROLIMUS (160) ETANERCEPT (135)

Which DICLOFENAC Alternatives Have Lower Inflammatory bowel disease Risk?

DICLOFENAC vs DICLOFENAC DIETHYLAMINE DICLOFENAC vs DICLOFENAC EPOLAMINE DICLOFENAC vs DICLOFENAC\DICLOFENAC DICLOFENAC vs DICLOFENAC\MISOPROSTOL DICLOFENAC vs DICLOXACILLIN

Related Pages

DICLOFENAC Full Profile All Inflammatory bowel disease Reports All Drugs Causing Inflammatory bowel disease DICLOFENAC Demographics